HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gualou Xiebai Banxia decoction ameliorates Poloxamer 407-induced hyperlipidemia.

AbstractETHNOPHARMACOLOGICAL RELEVANCE:
Gualou Xiebai Banxia (GLXBBX) decoction is a well-known traditional Chinese herbal formula that was first discussed in the Synopsis of the Golden Chamber by Zhang Zhongjing in the Eastern Han Dynasty. In traditional Chinese medicine, GLXBBX is commonly prescribed to treat cardiovascular diseases, such as coronary heart disease and atherosclerosis.
OBJECTIVE:
The present study aimed to examine GLXBBX's preventative capacity and elucidate the potential molecular mechanism of Poloxamer 407 (P407)-induced hyperlipidemia in rats.
MATERIALS AND METHODS:
Both the control and model groups received pure water, and the test group also received a GLXBBX decoction. For each administration, 3 ml of the solution was administered orally. To establish hyperlipidemia, a solution mixed with 0.25 g/kg P407 dissolved in 0.9% normal saline was injected slowly into the abdominal cavity. At the end of the study, the rats' plasma lipid levels were calculated using an automatic biochemical analyzer to evaluate the preventative capability of the GLXBBX decoction, and the serum and liver of the rats were collected.
RESULTS:
The GLXBBX decoction significantly improved P407-induced hyperlipidemia, including increased plasma triglycerides (TGs), aspartate aminotransferase (AST) elevation, and lipid accumulation. Moreover, GLXBBX decoction treatment increased lipoprotein lipase (LPL) activity and mRNA expression of LPL. Furthermore, GLXBBX significantly suppressed the mRNA expression of stearoyl-CoA desaturase (SCD1).
CONCLUSION:
GLXBBX significantly improved P407-induced hyperlipidemia, which may have been related to enhanced LPL activity, increased LPL mRNA expression, and decreased mRNA expression of SCD1.
AuthorsMingzhu Luo, Rong Fan, Xiaoming Wang, Junyu Lu, Ping Li, Wenbin Chu, Yonghe Hu, Xuewei Chen
JournalBioscience reports (Biosci Rep) Vol. 41 Issue 6 (06 25 2021) ISSN: 1573-4935 [Electronic] England
PMID34036306 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 The Author(s).
Chemical References
  • Biomarkers
  • Drugs, Chinese Herbal
  • Hypolipidemic Agents
  • Lipids
  • gualou xiebai banxia decoction
  • Poloxamer
  • Stearoyl-CoA Desaturase
  • stearoyl-CoA desaturase SCD-1, rat
  • Lipoprotein Lipase
Topics
  • Animals
  • Biomarkers (blood)
  • Disease Models, Animal
  • Drugs, Chinese Herbal (pharmacology)
  • Hyperlipidemias (blood, chemically induced, prevention & control)
  • Hypolipidemic Agents (pharmacology)
  • Lipids (blood)
  • Lipoprotein Lipase (genetics, metabolism)
  • Male
  • Poloxamer
  • Rats, Wistar
  • Stearoyl-CoA Desaturase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: